# PAIP2B

## Overview
PAIP2B is a gene that encodes the poly(A) binding protein interacting protein 2B, a regulatory protein involved in the modulation of mRNA translation and stability. This protein functions as a translational inhibitor by interacting with the poly(A) binding protein (PABP), thereby influencing the translation of polyadenylated mRNAs. PAIP2B achieves this by displacing PABP from the poly(A) tail, which reduces the formation of 80S ribosomal complexes necessary for translation initiation (DERRY2006Regulation; Berlanga2006Regulation). The protein is expressed in a tissue-specific manner, with notable expression in the pancreas, testis, brain, heart, lung, and pancreas, suggesting potential roles in tissue-specific regulatory mechanisms and glucose homeostasis (DERRY2006Regulation; Berlanga2006Regulation). PAIP2B's differential expression and stability compared to its homolog PAIP2A indicate unique regulatory functions and mechanisms (Berlanga2006Regulation). Additionally, PAIP2B has clinical significance as a potential biomarker for pancreatic ductal adenocarcinoma and may play a role in cancer progression and treatment efficacy (Mukherjee2021Identification; Xiang2023Integrative).

## Structure
The PAIP2B protein is a 123-amino-acid polypeptide with a predicted molecular weight of approximately 14.2 kDa. It shares 80% similarity and 59% identity with its homolog Paip2A, particularly in the central and C-terminal regions containing the poly(A) binding protein (PABP) interacting motifs (PAMs) (Berlanga2006Regulation). The protein has two independent binding sites for PABP: one located in the central acidic portion (residues 23-76) and another near the C terminus (residues 111-123) (Berlanga2006Regulation). These sites facilitate its role in inhibiting translation by displacing PABP from the poly(A) tail of mRNAs (Berlanga2006Regulation).

Paip2B is less ubiquitinated than Paip2A, resulting in a longer half-life, which suggests differential regulation through the ubiquitin/proteasome pathway (Berlanga2006Regulation). The protein's expression varies across tissues, with high levels in the testis, brain, heart, lung, and pancreas (Berlanga2006Regulation). Despite its functional similarities to Paip2A, Paip2B's distinct expression patterns and stability indicate potential tissue-specific roles and regulatory mechanisms (Berlanga2006Regulation). The molecular structure of PAIP2B, including its secondary, tertiary, and quaternary structures, is not detailed in the available literature.

## Function
PAIP2B (poly(A) binding protein interacting protein 2B) is a translational inhibitor that plays a crucial role in the regulation of mRNA stability and translation in healthy human cells. It interacts with the poly(A) binding protein (PABP) to modulate the translation of polyadenylated mRNAs by displacing PABP from the poly(A) tail, thereby reducing the affinity of PABP for polyadenylated RNA. This action inhibits the formation of 80S ribosomal complexes, which are essential for translation initiation (DERRY2006Regulation; Berlanga2006Regulation).

PAIP2B is expressed in a tissue-specific manner, with higher levels in the pancreas, suggesting a potential role in glucose homeostasis (DERRY2006Regulation). It is also involved in regulating the rate of mRNA deoxygenation and decay, which are critical for maintaining normal cellular processes and preventing cancerous transformations (Xiang2023Integrative). The protein is active in the cytoplasm, where it influences gene expression by modulating mRNA decay and translation efficiency (Berlanga2006Regulation).

The evolutionary divergence of PAIP2B from its homolog PAIP2A suggests distinct functions, although both proteins modulate PABP translational activity (DERRY2006Regulation). PAIP2B's role in translation regulation is further supported by its differential expression and degradation patterns compared to PAIP2A, indicating a unique regulatory mechanism (Berlanga2006Regulation).

## Clinical Significance
PAIP2B has been identified as a potential biomarker for pancreatic ductal adenocarcinoma (PDAC). Studies have shown that PAIP2B expression is significantly lower in pancreatic cancer tissues compared to normal tissues, and this reduced expression is associated with decreased cancer cell proliferation and invasion, as well as shorter median survival times for patients (Mukherjee2021Identification; Xiang2023Integrative). The downregulation of PAIP2B in PDAC is linked to DNA methylation, particularly at specific CG sites, which negatively correlates with its expression (Xiang2023Integrative).

PAIP2B is also involved in the regulation of immune cell interactions and drug efficacy in cancer treatment. Its expression levels correlate with the efficacy of certain drugs, suggesting that it could influence treatment outcomes (Xiang2023Integrative). Additionally, PAIP2B has been implicated in the epithelial-to-mesenchymal transition (EMT), a process crucial for cancer metastasis, highlighting its role in cancer progression (Mukherjee2021Identification).

In the context of retinal diseases, PAIP2B has been identified as a candidate photoreceptor gene, with potential implications for retinal pathophysiology if its involvement is confirmed (Pinelli2016An).

## Interactions
PAIP2B interacts with the poly(A) binding protein (PABP) and plays a significant role in translation regulation by modulating PABP's activity. PAIP2B binds to PABP at two independent sites: one in the central acidic portion (residues 23-76) and another near the C terminus (residues 111-123) (Berlanga2006Regulation). This interaction is crucial for PAIP2B's function as it inhibits translation by displacing PABP from the poly(A) tail of mRNAs, thereby reducing PABP's affinity for polyadenylated RNA (Berlanga2006Regulation).

PAIP2B competes with other PABP-interacting proteins, such as PAIP1, for binding to PABP, which affects the formation of 80S ribosomal complexes and inhibits translation (DERRY2006Regulation). This competitive binding also reduces the interaction between PABP and eIF4G, further inhibiting translation (DERRY2006Regulation). PAIP2B's interaction with PABP involves binding to the RNA recognition motifs (RRMs) and the PABC domain of PABP, which suppresses the translation of mRNAs with poly(A) tails (OZTURK2018Potential).

The interaction of PAIP2B with PABP is not only important for translation regulation but also for maintaining proper translational activity during specific biological processes, such as spermatogenesis (OZTURK2018Potential).


## References


[1. (DERRY2006Regulation) M.C. DERRY, A. YANAGIYA, Y. MARTINEAU, and N. SONENBERG. Regulation of poly(a)-binding protein through pabp-interacting proteins. Cold Spring Harbor Symposia on Quantitative Biology, 71(0):537–543, January 2006. URL: http://dx.doi.org/10.1101/sqb.2006.71.061, doi:10.1101/sqb.2006.71.061. This article has 96 citations and is from a peer-reviewed journal.](https://doi.org/10.1101/sqb.2006.71.061)

[2. (OZTURK2018Potential) Saffet OZTURK and Fatma UYSAL. Potential roles of the poly(a)-binding proteins in translational regulation during spermatogenesis. Journal of Reproduction and Development, 64(4):289–296, 2018. URL: http://dx.doi.org/10.1262/jrd.2018-026, doi:10.1262/jrd.2018-026. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1262/jrd.2018-026)

[3. (Berlanga2006Regulation) Juan José Berlanga, Alexis Baass, and Nahum Sonenberg. Regulation of poly(a) binding protein function in translation: characterization of the paip2 homolog, paip2b. RNA, 12(8):1556–1568, June 2006. URL: http://dx.doi.org/10.1261/rna.106506, doi:10.1261/rna.106506. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.106506)

[4. (Pinelli2016An) Michele Pinelli, Annamaria Carissimo, Luisa Cutillo, Ching-Hung Lai, Margherita Mutarelli, Maria Nicoletta Moretti, Marwah Veer Singh, Marianthi Karali, Diego Carrella, Mariateresa Pizzo, Francesco Russo, Stefano Ferrari, Diego Ponzin, Claudia Angelini, Sandro Banfi, and Diego di Bernardo. An atlas of gene expression and gene co-regulation in the human retina. Nucleic Acids Research, 44(12):5773–5784, May 2016. URL: http://dx.doi.org/10.1093/nar/gkw486, doi:10.1093/nar/gkw486. This article has 69 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkw486)

[5. (Xiang2023Integrative) Yaoxian Xiang, Li Wang, Yurong Cheng, Huanjuan An, Chan Zhang, Jing Wang, Yingying Tong, and Dong Yan. Integrative analysis of paip2b to identify a novel biomarker for pancreatic ductal adenocarcinoma. Global Medical Genetics, 10(04):388–394, December 2023. URL: http://dx.doi.org/10.1055/s-0043-1777789, doi:10.1055/s-0043-1777789. This article has 0 citations.](https://doi.org/10.1055/s-0043-1777789)

[6. (Mukherjee2021Identification) Moumita Mukherjee and Srikanta Goswami. Identification of key deregulated rna-binding proteins in pancreatic cancer by meta-analysis and prediction of their role as modulators of oncogenesis. Frontiers in Cell and Developmental Biology, November 2021. URL: http://dx.doi.org/10.3389/fcell.2021.713852, doi:10.3389/fcell.2021.713852. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.713852)